Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Revenue | 138M | 150M | 161M | 138M | 150M | 157M |
| Cost of revenue | 66M | 66M | 70M | 64M | 62M | 64M |
| Gross profit | 72M | 84M | 91M | 74M | 88M | 92M |
| Selling, general and administrative | 69M | 75M | 72M | 67M | 72M | 74M |
| Operating expenses | 89M | 100M | 99M | 89M | 95M | 101M |
| Operating income | −17M | −16M | −9M | −15M | −8M | −8M |
| Pre-tax income | −17M | −16M | −9M | −15M | −7M | −8M |
| Income tax | −6M | −5M | −2M | −4M | −2M | −2M |
| Net income | −11M | −11M | −7M | −11M | −5M | −6M |
| Earnings per share | −0.76 | −0.72 | −0.45 | −0.73 | −0.32 | −0.38 |
| Earnings per share, diluted | −0.76 | −0.72 | −0.45 | −0.73 | −0.32 | −0.38 |
| Weighted average shares | 15M | 15M | 15M | 15M | 16M | 16M |
| Weighted average shares, diluted | 15M | 15M | 15M | 15M | 16M | 16M |
| Metric | 30/04/2026 | 31/01/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/01/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 57M | 102M | 24M | 34M | 27M | 84M | 62M | 72M |
| Receivables | 13M | 12M | 17M |
| Metric | 30/04/2026 | 31/10/2025 | 31/07/2025 | 30/04/2025 | 31/10/2024 | 31/07/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −35M | — | — | −41M | — | — |
| Depreciation and amortisation | 4M | 4M | 4M | 4M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 14M |
| 13M |
| 17M |
| 16M |
| 15M |
| Current assets | 199M | 237M | 186M | 190M | 181M | 247M | 210M | 194M |
| Property, plant and equipment | 87M | 86M | 87M | 84M | 85M | 78M | 77M | 77M |
| Goodwill | 144,000 | 144,000 | 144,000 | 144,000 | 144,000 | 144,000 | 144,000 | 144,000 |
| Total assets | 501M | 535M | 496M | 494M | 484M | 532M | 500M | 481M |
| Current liabilities | 128M | 147M | 137M | 125M | 113M | 155M | 141M | 115M |
| Total liabilities | 295M | 316M | 306M | 296M | 283M | 316M | 303M | 279M |
| Equity | 206M | 219M | 189M | 197M | 201M | 216M | 196M | 202M |
| Shares outstanding | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 16M |
| Shares issued | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 16M |
| 4M |
| 4M |
| Share-based compensation | 2M | — | — | 3M | — | — |
| Capital expenditure | 5M | — | — | 9M | — | — |
| Investing cash flow | −5M | — | — | −9M | — | — |
| Share buybacks | 2M | — | — | 6M | — | — |
| Financing cash flow | −4M | — | — | −7M | — | — |